ANGIODYNAMICS INC — Director's Dealing 2019

Jul 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2019-07-18

Reporting Person: Boucher Brent J. (SVP and GM of Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-18	Common Stock	F	225	$21.53	Disposed	16544	Direct
2019-07-18	Common Stock	F	148	$21.53	Disposed	16396	Direct

Footnotes

F1: The exempt disposition of 225 shares of common stock of AngioDynamics, Inc. ("Common Stock") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.

F2: The exempt disposition of 148 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.